Susquehanna International Group
CLCD

Susquehanna International Group’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Susquehanna International Group’s Portfolio CLCD Stock Details CLCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-11,939
Closed -$435K – 10788
2016
Q4 		$435K Buy
+11,939
New +$422K ﹤0.01% 7282

Other funds holding CLCD

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Susquehanna International Group's CLCD Position: Q1 2017 in Review

Susquehanna International Group sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 11,939 shares — an estimated $435K sold.

Susquehanna International Group first reported a position in CLCD in Q4 2016 and held it in 1 quarter. The position peaked at $435K in Q4 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

  • Susquehanna International Group reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • Susquehanna International Group sold 11,939 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $435K.
  • Susquehanna International Group first reported a position in CoLucid Pharmaceuticals, Inc. in Q4 2016 and held it in 1 quarter.
  • Susquehanna International Group's CoLucid Pharmaceuticals, Inc. position peaked at $435K in Q4 2016.
  • 1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Susquehanna International Group's 13F filing for Q1 2017, filed 15 May 2017.